Supplemental material, sj-xlsx-1-ajs-10.1177_03635465211053869 for The Minimal Clinically Important Difference: A Review of Clinical Significance by David A. Bloom, Daniel J. Kaplan, Edward Mojica, Er
Sub-groups 1 (empirically treated participants) and sub-group 2 (participants with microbiologically-confirmed TB) are not mutually exclusive as some participants who were started on empiric TB treatm